✦ LIBER ✦

Pharmaceutical aspects of drug eluting stents

✍ Scribed by E. Deconinck; J. Sohier; I. De Scheerder; G. Van den Mooter

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 237 KB
Volume: 97
Category: Article
ISSN: 0022-3549
DOI: 10.1002/jps.21356

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of drug-eluting stent restenos

Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent

✍ Shaila Garg; Kimberly Smith; Rebecca Torguson; Teruo Okabe; Tina L. Pinto Slotto 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 3 views

Outcomes of diabetics receiving bare-met

Outcomes of diabetics receiving bare-metal stents versus drug-eluting stents

✍ Vijay S. Ramanath; Jeremiah R. Brown; David J. Malenka; James T. DeVries; Mandee 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB 👁 2 views

Drug eluting stents for everyone and eve

Drug eluting stents for everyone and everything?

✍ Roger J. Laham 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

Gender medicine and drug eluting coronar

Gender medicine and drug eluting coronary stents

✍ Ran Kornowski 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

Very late thrombosis after drug-eluting

Very late thrombosis after drug-eluting stents

✍ Fausto Feres; J. Ribamar Costa Jr.; Alexandre Abizaid 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB 👁 2 views

## Abstract Stent thrombosis is a rare but potentially fatal complication of percutaneous treatment of coronary disease. Its occurrence after drug eluting stent (DES) placement has raised concerns, especially when it occurs late after the stent implantation. The mechanisms of late thrombosis after

Drug eluting stents in CTOs: Why not?

✍ George W. Vetrovec 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB 👁 2 views